|Last Price||Today's Change||52-Week Range||Trading Volume|
|0.11 CAD||0.00 (0.00%)||0.04 - 0.57||0.0|
Market data as of 12:00AM 08/27/15. Quotes are delayed by at least 15 min.
Antibe Therapeutics Reports Q1 2016 Interim Financial and Operating Results and a Further Update on Its Validation Studies
Business Wire - Thursday 08/27/2015 8:45 AM ET
Antibe Announces Completion of Phase I Studies of ATB-346 and an Update on Its Validation Studies
Business Wire - Monday 08/10/2015 7:00 AM ET
|Revenue Growth (1yr)||--|
|Net Income Growth (1yr)||--|
Data is delayed by at least 15 min.